|
Real-time Estimate
Cboe Europe
09:46:43 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 14.34 CHF | -0.55% |
|
-2.19% | +13.17% |
| 09-30 | Santhera Pharmaceuticals Holding AG, H1 2026 Earnings Call, Sep 30, 2026 | |
| 09-30 | Swiss Market Index Extends Losses Amid Higher Economic Growth Projections | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Specialty & Advanced Pharmaceuticals | -0.42% | -2.19% | +13.17% | +35.55% | +3.94% | 268M |  | |  |
- Stock Market
- Stocks
- SANN Stock
- Charts Santhera Pharmaceuticals Holding AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
